Publication | Closed Access
Use of Recombinant Interferon Alfa-2b in the Treatment of Basal Cell Carcinoma
56
Citations
0
References
1995
Year
Based on our results, intra- and perilesional IFN alfa-2b represents an effective, alternative treatment for BCC.